$43.12
0.390.91%
At Close: -
$43.12
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Xenon Pharmaceuticals
XENENASDAQ
Xenon Pharmaceuticals (NASDAQ:XENE) Stock, Earnings Estimates, EPS, And Revenue
Xenon Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 7
EPS Estimate
$-0.700
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Xenon Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals | -$0.72 | -$0.70 | — | — | $0.00 | — | — | — | 08/07/2024 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.63 | -$0.66 | -$0.62 | 6.06% | $0.00 | — | $0.00 | — | 05/09/2024 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.57 | -$0.76 | -$0.64 | 15.79% | $0.00 | $1.89M | $0.00 | -100.00% | 02/29/2024 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.57 | -$0.77 | -$0.73 | 5.19% | $132.00K | $1.45M | $0.00 | -100.00% | 11/08/2023 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.55 | -$0.70 | -$0.72 | -2.86% | $536.00K | $400.00K | $0.00 | -100.00% | 08/09/2023 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.35 | -$0.62 | -$0.63 | -1.61% | $8.77M | $570.00K | $0.00 | -100.00% | 05/09/2023 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.48 | -$0.58 | -$0.57 | 1.72% | $3.74M | $2.28M | $0.00 | -100.00% | 03/01/2023 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.36 | -$0.52 | -$0.57 | -9.62% | $8.12M | $3.02M | $132.00K | -95.63% | 11/08/2022 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.51 | -$0.48 | -$0.55 | -14.58% | $2.22M | $3.55M | $536.00K | -84.90% | 08/09/2022 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.42 | -$0.41 | -$0.35 | 14.63% | $4.36M | $8.70M | $8.77M | 0.76% | 05/10/2022 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.34 | -$0.37 | -$0.48 | -29.73% | $5.15M | $4.97M | $3.74M | -24.81% | 03/01/2022 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.25 | -$0.38 | -$0.36 | 5.26% | $6.55M | $10.22M | $8.12M | -20.51% | 11/10/2021 | Get Alert |
| XENE | Xenon Pharmaceuticals | $0.00 | -$0.48 | -$0.51 | -6.25% | $13.38M | $2.33M | $2.22M | -4.81% | 08/11/2021 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.22 | -$0.40 | -$0.42 | -5.00% | $7.08M | $5.15M | $4.36M | -15.38% | 05/11/2021 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.41 | -$0.40 | -$0.34 | 15.00% | $3.33M | $3.22M | $5.15M | 59.94% | 03/01/2021 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.33 | -$0.15 | -$0.25 | -66.67% | $3.50M | $10.06M | $6.55M | -34.85% | 11/05/2020 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.37 | -$0.24 | $0.00 | 100.00% | $0.00 | $6.90M | $13.38M | 93.97% | 08/06/2020 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.42 | -$0.32 | -$0.22 | 31.25% | $0.00 | $4.50M | $7.08M | 57.29% | 05/21/2020 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.29 | -$0.49 | -$0.41 | 16.33% | $0.00 | $5.00M | $3.33M | -33.42% | 03/09/2020 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.63 | -$0.48 | -$0.33 | 31.25% | $0.00 | — | $3.50M | — | 11/05/2019 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.45 | -$0.46 | -$0.37 | 19.57% | $0.00 | — | $0.00 | — | 08/06/2019 | Get Alert |
Xenon Pharmaceuticals (XENE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-0.62 | $-0.66 | 6.06 % |
| Dec 2023 | 2024-02-29 | $-0.64 | $-0.76 | 15.8 % |
| Sep 2023 | 2023-11-08 | $-0.73 | $-0.77 | 5.19 % |
| Jun 2023 | 2023-08-09 | $-0.72 | $-0.70 | -2.86 % |
Xenon Pharmaceuticals (XENE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-02-29 | $0 | $1.89M | -100.0 % |
| Sep 2023 | 2023-11-08 | $0 | $1.45M | -100.0 % |
| Jun 2023 | 2023-08-09 | $0 | $400.00K | -100.0 % |
| Mar 2023 | 2023-05-09 | $0 | $570.00K | -100.0 % |
FAQ
When is Xenon Pharmaceuticals (NASDAQ:XENE) reporting earnings?
Xenon Pharmaceuticals (XENE) is scheduled to report earnings on August 7, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Xenon Pharmaceuticals (NASDAQ:XENE)?
The Actual EPS was $-0.62, which beat the estimate of $-0.66.
What were Xenon Pharmaceuticals’s (NASDAQ:XENE) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.